Another approach to recruiting T cells into tumor is to use constructs expressing a chemokine receptor, such as CCR2, CCR2b, CXCR3, CCR4, CCR7, CXCR2, or CXCR4, which can interact with the relevant tumor-derived chemokine. The gene discussed is CXCR3; the disease is neoplasm.